Monthly View Flat View Weekly View Daily View Categories

Event: 'Reducing Cardiovascular Risk and Renal Risk With SGLT2 Inhibitors: Exploring the Evidence'


CME Satellite Symposium

Date: Sunday, September 15, 2019 (06:30 PM-08:00 PM)
Duration: 2 Hour(s)
  Location: Pennsylvania Convention Center • Room 201 A/B • 1101 Arch Street • Philadelphia, Pennsylvania

Faculty: Mikhail Kosiborod, MD(Chair); George Bakris, MD; Robert Mentz, MD.
Summary: In this program, expert faculty members will discuss the intertwined relationship between diabetes and HF, explain clinical trial data with SGLT2 inhibitors on cardiovascular, HF, and renal outcomes, and describe best practices for incorporating SGLT2 inhibitors into patient management.